Treace Medical Concepts, Inc. - Laporan Laba Rugi (TTM)

Treace Medical Concepts, Inc.
US ˙ NasdaqGS ˙ US89455T1097

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Treace Medical Concepts, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 57 65 78 85 94 105 114 126 142 155 167 175 187 196 199 203 209 211 214
Change (%) 12.99 19.93 9.46 10.97 10.95 8.89 10.03 13.01 9.27 7.73 4.61 7.12 4.76 1.28 2.18 3.20 0.70 1.39
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 12 13 15 17 17 20 21 23 26 28 31 33 35 37 38 39 41 42 42
Change (%) 7.52 13.86 8.75 1.72 16.23 6.86 8.78 11.89 11.39 8.38 6.19 7.48 5.94 2.97 2.49 4.48 1.34 2.05
% of Revenue 21.74 20.69 19.64 19.51 17.89 18.74 18.39 18.18 18.00 18.35 18.46 18.74 18.80 19.01 19.33 19.39 19.63 19.75 19.88
Gross Operating Profit 45 51 62 68 78 85 93 103 116 127 136 142 152 159 160 164 168 169 171
Change (%) 14.51 21.51 9.63 13.21 9.80 9.36 10.31 13.26 8.80 7.59 4.26 7.04 4.49 0.88 2.11 2.89 0.54 1.23
% of Revenue 78.26 79.31 80.36 80.49 82.11 81.26 81.61 81.82 82.00 81.65 81.54 81.26 81.20 80.99 80.67 80.61 80.37 80.25 80.12
SG&A 38 44 57 67 84 97 112 126 138 153 163 175 188 198 206 206 203 201 198
Change (%) 16.45 27.32 18.35 25.11 15.64 15.77 12.64 8.81 11.31 6.65 7.19 7.36 5.41 4.09 0.04 -1.41 -1.37 -1.33
% of Revenue 66.58 68.62 72.84 78.76 88.79 92.54 98.39 100.73 96.99 98.80 97.80 100.21 100.43 101.05 103.86 101.68 97.14 95.15 92.59
R&D 6 6 8 9 10 11 12 13 14 14 14 15 15 17 19 20 21 21 21
Change (%) 7.44 22.92 13.30 16.63 11.60 4.94 10.56 2.82 2.65 3.89 3.80 2.68 11.96 9.43 3.24 5.15 1.48 1.64
% of Revenue 10.19 9.69 9.93 10.28 10.81 10.87 10.48 10.53 9.58 9.00 8.68 8.61 8.25 8.82 9.53 9.63 9.81 9.88 9.91
OpEx 57 64 80 92 111 128 145 162 177 196 209 223 239 253 263 265 265 263 262
Change (%) 13.54 24.08 16.02 20.10 15.36 13.44 11.91 8.76 10.66 6.70 6.81 7.06 5.91 4.29 0.62 -0.05 -0.73 -0.56
% of Revenue 98.51 98.99 102.42 108.55 117.49 122.15 127.25 129.44 124.57 126.15 124.94 127.56 127.48 128.88 132.71 130.69 126.57 124.78 122.38
Operating Income 1 1 -2 -7 -17 -23 -31 -37 -35 -41 -42 -48 -51 -57 -65 -62 -56 -52 -48
Change (%) -23.74 -388.50 286.92 126.85 40.55 33.97 18.84 -5.68 16.30 2.76 15.61 6.82 10.10 14.71 -4.13 -10.65 -6.09 -8.44
% of Revenue 1.49 1.01 -2.42 -8.55 -17.49 -22.15 -27.25 -29.44 -24.57 -26.15 -24.94 -27.56 -27.48 -28.88 -32.71 -30.69 -26.57 -24.78 -22.38
Interest Expense -3 -3 -4 -4 -4 -4 -4 -4 -4 -5 -5 -5 -5 -5 -5 -5 -5 -5 -5
Change (%) 21.25 17.23 3.93 -1.02 -1.97 -2.31 5.84 6.88 7.59 7.10 2.09 -0.14 0.62 0.58 0.33 0.19 -0.11 0.17
% of Revenue -4.84 -5.19 -5.08 -4.82 -4.30 -3.80 -3.41 -3.28 -3.10 -3.05 -3.04 -2.96 -2.76 -2.65 -2.63 -2.59 -2.51 -2.49 -2.46
Net Income -4 -4 -8 -11 -21 -27 -39 -45 -43 -47 -42 -48 -50 -55 -64 -62 -56 -53 -49
Change (%) 22.49 69.22 49.49 80.82 32.13 44.75 14.54 -4.90 10.32 -10.51 12.75 3.92 10.54 16.32 -3.39 -9.39 -4.94 -7.19
% of Revenue -6.39 -6.93 -9.78 -13.36 -21.77 -25.92 -34.46 -35.87 -30.19 -30.48 -25.32 -27.28 -26.47 -27.93 -32.08 -30.33 -26.63 -25.13 -23.01

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista